Eyegate Pharma (EYEG) Unit Receives Additional USAMRMC Funding for CMHA-S Development
Tweet Send to a Friend
EyeGate Pharmaceuticals, Inc. (Nasdaq: EYEG) announced that Jade Therapeutics, Inc. (“Jade”), a wholly owned subsidiary of EyeGate, has received the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
